Recurrent Nonobstructive Cholangitis After Pancreaticoduodenectomy: Prevalence, Risk Factors, and Treatment
World Journal of Surgery · 2025
DOI: 10.1002/wjs.70037 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Surgery, 2025. Verfasst von Anaïs Choquet und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of HPB Surgery, AP-HP, Beaujon Hospital, University of Paris-Cité, Clichy, France. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Cholangitis, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Recurrent nonobstructive cholangitis (RNOC) due to enterobiliary reflux is a late complication of pancreaticoduodenectomy (PD) that should be differentiated from obstructive cholangitis. The risk factors (RFs) of RNOC are poorly known. The goal of this study was to estimate the prevalence, to identify the RF, and to describe the management of RNOC following PD.
Methods
This case–control study included 503 patients from a prospective database (2014–2018) who underwent PD; one hundred and eighty‐three patients were excluded because they had less than 1‐year of follow‐up, tumor recurrence during postoperative year one, or cholangitis from anastomotic stenosis or tumor recurrence. RNOC was defined as at least 3 episodes of cholangitis that occurred or persisted more than 1‐year after PD, without anastomotic stenosis or tumor recurrence. RF were identified by univariate and multivariate analyses.
Results
Of the 320 analyzed patients, 213 (67%) and 107 (33%) underwent PD for malignancy and a benign lesion, respectively. With a median follow‐up of 47 months (IQR: 33–68), 27 of the 320 patients (8%) developed RNOC (median number of episodes = 8 and IQR = 5–12). The only independent RF for RNOC was noninvasive IPMN (OR = 3.222; IC‐95% = 1.219–8.514; and p = 0.018). All patients received on‐demand antibiotics. Three patients (11%) developed complications from RNOC (hepatic abscesses in 3 and organ failure in one). No patients died from RNOC. Two (7%) patients underwent reoperation to lengthen the biliary Roux‐en‐Y loop but RNOC persisted in both.
Conclusions
RNOC complicates 8% of PD. Noninvasive IPMN was a RF of RNOC. The value of revision surgery to limit the risk of recurrence seems limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of HPB Surgery, AP-HP, Beaujon Hospital, University of Paris-Cité, Clichy, France.
- Department of Internal Medecine, AP-HP, Beaujon Hospital, University of Paris-Cité, Clichy, France.
- Department of Pancreatology, AP-HP, Beaujon Hospital, University of Paris-Cité, Clichy, France.
ORCID-Profile: Alain Sauvanet
Zitieren
APA
Choquet, A., Sokal, A., Dokmak, S., Le Bot, A., Delahaye, F., Dembinski, J., Aussilhou, B., Rebours, V., de Lastours, V., & Sauvanet, A. (2025). Recurrent Nonobstructive Cholangitis After Pancreaticoduodenectomy: Prevalence, Risk Factors, and Treatment. World Journal of Surgery. https://doi.org/10.1002/wjs.70037
Vancouver
Choquet A, Sokal A, Dokmak S, Le Bot A, Delahaye F, Dembinski J, et al. Recurrent Nonobstructive Cholangitis After Pancreaticoduodenectomy: Prevalence, Risk Factors, and Treatment. World Journal of Surgery. 2025. doi:10.1002/wjs.70037
BibTeX
@article{Choquet2025,
author = {Choquet, Anaïs and Sokal, Aurélien and Dokmak, Safi and Le Bot, Audrey and Delahaye, Fanny and Dembinski, Jeanne and Aussilhou, Béatrice and Rebours, Vinciane and de Lastours, Victoire and Sauvanet, Alain},
title = {Recurrent Nonobstructive Cholangitis After Pancreaticoduodenectomy: Prevalence, Risk Factors, and Treatment},
journal = {World Journal of Surgery},
year = {2025},
doi = {10.1002/wjs.70037}
}
EUVIMED